Skip to content
Open access · CC-BY via OpenAlex

Sarcopenia and diabetes: Hyperglycemia is a risk factor for age‐associated muscle mass and functional reduction

Hiroyuki Umegaki

Journal of Diabetes Investigation · 2015 · ▲ 123 citations

Abstract

Kalyani et al. recently reported that hyperglycemia is associated with sarcopenia. Blood-glucose-lowering therapy may prevent the progression of sarcopenia in subjects with D<\M.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1111/jdi.12365
Canonical
link ↗
Fetched
2026-10-17 MST

Cite this

APA
Umegaki, H. (2015). Sarcopenia and diabetes: Hyperglycemia is a risk factor for age‐associated muscle mass and functional reduction. <em>Journal of Diabetes Investigation</em>. https://doi.org/10.1111/jdi.12365
Vancouver
Umegaki H. Sarcopenia and diabetes: Hyperglycemia is a risk factor for age‐associated muscle mass and functional reduction. Journal of Diabetes Investigation. 2015. doi:10.1111/jdi.12365.
BibTeX
@article{hiroyuki2015Sarcop, title = {Sarcopenia and diabetes: Hyperglycemia is a risk factor for age‐associated muscle mass and functional reduction}, author = {Hiroyuki Umegaki}, journal = {Journal of Diabetes Investigation}, year = {2015}, doi = {10.1111/jdi.12365}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings

Wiener Medizinische Wochenschrift 2018
Citation only

Sarcopenia

▲ 102
Clinics in Geriatric Medicine 2010
Citation only

Sarcopenia

▲ 94
Clinics in Geriatric Medicine 2017
Citation only

Sarcopenia

▲ 125
Nature Reviews Disease Primers 2024
Citation only

Sarcopenia

▲ 381
The Lancet 2019
Citation only

Sarcopenia

▲ 3,875
Joint Bone Spine 2018
Open access · OA

Sarcopenia

▲ 370